The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Thiazolidinedione Use and Bone Loss in Older Diabetic Adults
Open accessAbstract
CONTEXT: Activation of peroxisome proliferator-activated receptor-gamma by thiazolidinediones (TZDs) results in lower bone mass in mice. OBJECTIVE: The objective of the study was to determine whether TZD use is associated with changes in bone mineral density (BMD) in older adults with type 2 diabetes. DESIGN: We analyzed 4-yr follow-up data from the Health, Aging, and Body Composition observational study. SETTING: The study was conducted in a general community. PATIENTS: White and black, physically able men and women, aged 70-79 yr at baseline with diabetes defined by self-report, use of hypoglycemic medication, elevated fasting glucose (>/=126 mg/dl), or elevated 2-h glucose tolerance test (>/=200 mg/dl) participated in the study. MAIN OUTCOME MEASURES: Whole-body, lumbar spine (derived from whole body), and hip BMD were measured by dual-energy x-ray absorptiometry at 2-yr intervals. RESULTS: Of 666 diabetic participants, 69 reported TZD use at an annual visit, including troglitazone (n = 22), pioglitazone (n = 30), and/or rosiglitazone (n = 31). Those with TZD use had higher baseline hemoglobin A(1c) and less weight loss over 4 yr but similar baseline BMD and weight than others with diabetes. In repeated-measures models adjusted for potential confounders associated with TZD use and BMD, each year of TZD use was associated with greater bone loss at the whole body [additional loss of -0.61% per year; 95% confidence interval (CI) -1.02, -0.21% per year], lumbar spine (-1.23% per year; 95% CI -2.06, -0.40% per year), and trochanter (-0.65% per year; 95% CI -1.18, -0.12% per year) in women, but not men, with diabetes. CONCLUSION: These observational results suggest that TZDs may cause bone loss in older women. These results need to be tested in a randomized trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Generalized, Linear, and Mixed Models
McCulloch, C. E., & Searle, S. R. (2000) · Wiley Series in Probability and Statistics · doi:10.1002/0471722073 · Cited by 2,994
Older Women with Diabetes Have an Increased Risk of Fracture: A Prospective Study
Schwartz, A. V. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.32 · Cited by 789
Self-citationBone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.
de Liefde, I. I., van der Klift, M., de Laet, C. E. D. H., van Daele, P. L. A., Hofman, A., & Pols, H. A. P. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1909-1 · Cited by 555
Azziz, R., Ehrmann, D., Legro, R. S., Whitcomb, R. W., Hanley, R., Fereshetian, A. G., O’Keefe, M., & Ghazzi, M. N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7375 · Cited by 517
Drug data coding and analysis in epidemiologic studies
Pahor, M., Chrischilles, E. A., Guralnik, J. M., Brown, S. L., Wallace, R. B., & Carbonin, P. (1994) · European Journal of Epidemiology · doi:10.1007/bf01719664 · Cited by 490
Bone Is a Target for the Antidiabetic Compound Rosiglitazone
Rzonca, S. O., Suva, L. J., Gaddy, D., Montague, D. C., & Lecka-Czernik, B. (2004) · Endocrinology · doi:10.1210/en.2003-0746 · Cited by 454
Self-citationStrotmeyer, E. S., Cauley, J. A., Schwartz, A. V., Nevitt, M. C., Resnick, H. E., Bauer, D. C., Tylavsky, F. A., de Rekeneire, N., Harris, T. B., & Newman, A. B. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.14.1612 · Cited by 377
Self-citationAzziz, R. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1626 · Cited by 376
Strotmeyer, E. S., Cauley, J. A., Schwartz, A. V., Nevitt, M. C., Resnick, H. E., Zmuda, J. M., Bauer, D. C., Tylavsky, F. A., de Rekeneire, N., Harris, T. B., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040311 · Cited by 218
Self-citationRosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis
Sorocéanu, M. A., Miao, D., Bai, X.-Y., Su, H., Goltzman, D., & Karaplis, A. C. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05723 · Cited by 199
Rubin, G., Zhao, Y., Kalus, A. M., & Simpson, E. R. (2000) · PubMed · Cited by 198
Femoral bone loss progresses with age: A longitudinal study in women over age 65
Greenspan, S. L., Maitland, L. A., Myers, E. R., Krasnow, M. B., & Kido, T. H. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091216 · Cited by 180
Sottile, V., Seuwen, K., & Kneissel, M. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0224-8 · Cited by 178
Arlt, W., Auchus, R. J., & Miller, W. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100040200 · Cited by 157
Tornvig, L., Mosekilde, L., Justesen, J., Falk, E., & Kassem, M. S. (2001) · Calcified Tissue International · doi:10.1007/s002230020018 · Cited by 118
Rapid Increase in the Use of Oral Antidiabetic Drugs in the United States, 1990–2001
Wysowski, D. K., Armstrong, G., & Governale, L. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1852 · Cited by 105
Sornay‐Rendu, E., Munoz, F., Duboeuf, F., & Delmas, P. D. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050704 · Cited by 96
Osteoporosis assessment by whole body region vs. site-specific DXA
Melton, L. J., Looker, A. C., Shepherd, J., O’Connor, M. K., Achenbach, S. J., Riggs, B. L., & Khosla, S. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1871-y · Cited by 69
Effect of radiographic abnormalities on rate of bone loss from the spine
Dawson‐Hughes, B., & Dallal, G. E. (1990) · Calcified Tissue International · doi:10.1007/bf02555008 · Cited by 65
Tylavsky, F. A., Lohman, T. G., Dockrell, M., Lang, T., Schoeller, D. A., Wan, J. Y., Fuerst, T. P., Cauley, J. A., Nevitt, M. C., & Harris, T. B. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.2.356 · Cited by 65
Self-citationWatanabe, S. T., Takeuchi, Y., Fukumoto, S., Fujita, H. M., Nakano, T., & Fujita, T. (2003) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740300026 · Cited by 58
Okazaki, R., Miura, M., Toriumi, M., et al. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.795 · Cited by 55
Vierhapper, H., Nowotny, P., & Waldhäusl, W. K. (2003) · Metabolism · doi:10.1053/meta.2003.50028 · Cited by 40
Glitazones and the management of insulin resistance: what they do and how might they be used
EINHORN, D. F., Aroda, V. R., & Henry, R. R. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.04.003 · Cited by 27
Ex vivo bone mineral density of the wrist: influence of medullar fat
Chappard, D., Moquereau, M., Mercier, P., Gallois, Y., Legrand, É., Baslé, M. F., & Audran, M. (2004) · Bone · doi:10.1016/j.bone.2004.02.002 · Cited by 16
Cited by
Nathan, D. M., Buse, J. B., Davidson, M. B., Heine, R. J., Holman, R. R., Sherwin, R., & Zinman, B. (2006) · Diabetes Care · doi:10.2337/dc06-9912 · Cited by 1,203
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2016) · Endocrine Practice · doi:10.4158/ep151126.cs · Cited by 878
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
Age-related changes in total and regional fat distribution
Kuk, J. L., Saunders, T. J., Davidson, L. E., & Ross, R. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.06.001 · Cited by 778
“It is reported that thiazolidinediones may increase adipogenesis and decrease osteoblast formation in the bone marrow of mice (Rzonca et al., 2004) and diabetic women, but not men (Schwartz et al., 2006).”
Metadata
- Authors
- Schwartz, A. V., Sellmeyer, D. E., Vittinghoff, E., Palermo, L., Lecka-Czernik, B., Feingold, K. R., Strotmeyer, E. S., Resnick, H. E., Carbone, L., Beamer, B. A., Park, S. W., Lane, N. E., Harris, T. B., & Cummings, S. R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-09
- Volume
- 91
- Issue
- 9
- Pages
- 3349-3354
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2116822087
- Cited by
- 500
- References
- 26
- FWCI
- 54.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.